No abstract

levels were positive in their second-look. 70% of patients with residual tumors having the greatest diameter less than or equal to 2 cm had normal CA125 with a mean value of 21 u/ml. 42% of patients with tumors having the greatest diameter greater than 2 cm had normal CA125, while all the 8 patients with no macroscopic tumor during surgery had normal CA125 level. These results show that the residual tumor size found in the second-look was related to the serum CA125 level. Conclusion As CA125 levels within normal limits gave more false negatives, the necessity of second-look surgery can not be judged by serum CA125 assay though elevated CA125 levels do predict the presence of tumor.

Introduction/Background* Minimal invasive surgery for interval debulking surgery for stage IV ovarian cancer -52 years old -CT&MRI -11 cm adnexal mass and peritoneal carcinomatosis -PET scan: -Left pleural effusion. -Increased pleural FDG uptake -Giant hypermetabolic adnexal mass Methodology Video recorded surgery Result(s)* Optimal cytorreduction after 3 cycles of chemotherapy. Conclusion* Minimally invasive surgery may be considered for the management of patients with advanced ovarian cancer who have undergone neoadjuvant chemotherapy